130 related articles for article (PubMed ID: 35147068)
1.
Nigam K; Kaur A; Tyagi A; Manda K; Goswami N; Nematullah M; Khan F; Gabrani R; Gauba P; Dang S
J Microencapsul; 2022 Mar; 39(2):95-109. PubMed ID: 35147068
[TBL] [Abstract][Full Text] [Related]
2. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
[TBL] [Abstract][Full Text] [Related]
3. Baclofen-Loaded Poly (D,L-Lactide-Co-Glycolic Acid) Nanoparticles for Neuropathic Pain Management:
Nigam K; Kaur A; Tyagi A; Manda K; Gabrani R; Dang S
Rejuvenation Res; 2019 Jun; 22(3):235-245. PubMed ID: 30175946
[TBL] [Abstract][Full Text] [Related]
4. Protein-functionalized PLGA nanoparticles of lamotrigine for neuropathic pain management.
Lalani J; Patil S; Kolate A; Lalani R; Misra A
AAPS PharmSciTech; 2015 Apr; 16(2):413-27. PubMed ID: 25354788
[TBL] [Abstract][Full Text] [Related]
5. Lamotrigine loaded PLGA nanoparticles intended for direct nose to brain delivery in epilepsy: pharmacokinetic, pharmacodynamic and scintigraphy study.
Shah P; Dubey P; Vyas B; Kaul A; Mishra AK; Chopra D; Patel P
Artif Cells Nanomed Biotechnol; 2021 Dec; 49(1):511-522. PubMed ID: 34151674
[TBL] [Abstract][Full Text] [Related]
6. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
7. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles.
Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z
Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432
[TBL] [Abstract][Full Text] [Related]
8. Ferulic acid-loaded polymeric nanoparticles prepared from nano-emulsion templates facilitate internalisation across the blood-brain barrier in model membranes.
Garcia L; Palma-Florez S; Espinosa V; Soleimani Rokni F; Lagunas A; Mir M; García-Celma MJ; Samitier J; Rodríguez-Abreu C; Grijalvo S
Nanoscale; 2023 May; 15(17):7929-7944. PubMed ID: 37067009
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin.
Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS
AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560
[TBL] [Abstract][Full Text] [Related]
10. Diclofenac sodium loaded PLGA nanoparticles for inflammatory diseases with high anti-inflammatory properties at low dose: Formulation, characterization and in vivo HET-CAM analysis.
Öztürk AA; Namlı İ; Güleç K; Kıyan HT
Microvasc Res; 2020 Jul; 130():103991. PubMed ID: 32105668
[TBL] [Abstract][Full Text] [Related]
11. Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system.
Wang H; Liu J; Tao S; Chai G; Wang J; Hu FQ; Yuan H
Int J Nanomedicine; 2015; 10():5671-85. PubMed ID: 26388691
[TBL] [Abstract][Full Text] [Related]
12. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
[TBL] [Abstract][Full Text] [Related]
13. Preparation and Evaluation of Irinotecan Poly(Lactic-co-Glycolic Acid) Nanoparticles for Enhanced Anti-tumor Therapy.
Yang X; Yang Y; Jia Q; Hao Y; Liu J; Huang G
AAPS PharmSciTech; 2019 Feb; 20(3):133. PubMed ID: 30820689
[TBL] [Abstract][Full Text] [Related]
14. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
[TBL] [Abstract][Full Text] [Related]
15. Nose to Brain Delivery of Transferrin conjugated PLGA nanoparticles for clonidine.
Sharma S; Tyagi A; Dang S
Int J Biol Macromol; 2023 Dec; 252():126471. PubMed ID: 37619678
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Meng Q; Wang A; Hua H; Jiang Y; Wang Y; Mu H; Wu Z; Sun K
Int J Nanomedicine; 2018; 13():705-718. PubMed ID: 29440896
[TBL] [Abstract][Full Text] [Related]
17. Preparation, evaluation, and
Pan X; Liu S; Ju L; Xi J; He R; Zhao Y; Zhuang R; Huang J
Drug Dev Ind Pharm; 2020 Nov; 46(11):1889-1897. PubMed ID: 32975456
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
[TBL] [Abstract][Full Text] [Related]
19. Hybrid Cell Membrane-Functionalized Biomimetic Nanoparticles for Targeted Therapy of Osteosarcoma.
Cai JX; Liu JH; Wu JY; Li YJ; Qiu XH; Xu WJ; Xu P; Xiang DX
Int J Nanomedicine; 2022; 17():837-854. PubMed ID: 35228800
[TBL] [Abstract][Full Text] [Related]
20. Optimization and Appraisal of Chitosan-Grafted PLGA Nanoparticles for Boosting Pharmacokinetic and Pharmacodynamic Effect of Duloxetine HCl Using Box-Benkhen Design.
Salem HF; Ali AA; Rabea YK; Abo El-Ela FI; Khallaf RA
J Pharm Sci; 2023 Feb; 112(2):544-561. PubMed ID: 36063878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
